Nuwellis (NUWE) Shares Outstanding (Weighted Average) (2011 - 2026)
Nuwellis (NUWE) reported Shares Outstanding (Weighted Average) of $2.1 million for Q1 2026, up 1892.47% on a YoY basis from $104142.0 in Q1 2025, and up 200.66% quarter-over-quarter from $690145.0 in Q4 2025.
Nuwellis (NUWE) Shares Outstanding (Weighted Average) (2011 - 2026) Analysis & Trends
Nuwellis has reported Shares Outstanding (Weighted Average) for 16 years, with the latest figure at $2.1 million in Q1 2026.
- For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 1892.47% year-over-year to $2.1 million; the trailing twelve-month figure through Mar 2026 stood at $2.1 million (up 1892.47% YoY), and the FY2025 full-year result was $690145.0, up 2083.93% from the prior year.
- Shares Outstanding (Weighted Average) for Q1 2026 stood at $2.1 million, up from $690145.0 in the prior quarter.
- The five-year high for Shares Outstanding (Weighted Average) was $2.1 million in Q1 2026, with the low at $31601.0 in Q4 2024.
- Historically, Shares Outstanding (Weighted Average) has averaged $336554.8 across 5 years, with a median of $105000.0 in 2022.
- Annual changes were most pronounced in 2022 — Shares Outstanding (Weighted Average) sank 98.39% — and 2025, when it jumped 2083.93%.
- Nuwellis' Shares Outstanding (Weighted Average) stood at $174000.0 in 2022, then tumbled by 67.74% to $56126.0 in 2023, then tumbled by 43.7% to $31601.0 in 2024, then jumped by 2083.93% to $690145.0 in 2025, then jumped by 200.66% to $2.1 million in 2026.
- The last three Shares Outstanding (Weighted Average) figures came in at $2.1 million (Q1 2026), $690145.0 (Q4 2025), and $382000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.74 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 382.90 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.28 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.48 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 579.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 385.10 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 456.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 98.20 Mn |
| 10 | Nuwellis | 279,710.00 | -1.80 Mn | 1.68 Mn | 2.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.08 Mn |
| Dec 31, 2025 | 690,145.00 |
| Sep 30, 2025 | 382,000.00 |
| Jun 30, 2025 | 205,839.00 |
| Mar 31, 2025 | 104,142.00 |
| Dec 31, 2024 | 31,601.00 |
| Sep 30, 2024 | 204,710.00 |
| Jun 30, 2024 | 86,261.00 |
| Mar 31, 2024 | 179,608.00 |
| Dec 31, 2023 | 56,126.00 |
| Sep 30, 2023 | 53,000.00 |
| Jun 30, 2023 | 38,000.00 |
| Mar 31, 2023 | 1.13 Mn |
| Dec 31, 2022 | 174,000.00 |
| Sep 30, 2022 | 105,000.00 |
| Jun 30, 2022 | 105,000.00 |
| Mar 31, 2022 | 105,000.00 |
| Dec 31, 2021 | 69,000.00 |
| Sep 30, 2021 | 5.62 Mn |
| Jun 30, 2021 | 6.53 Mn |